June 13, 2017

ACI's 8th Annual Summit on Biosimilars

New York

Overview

Join Faegre Baker Daniels' Jessica Cox for a discussion assessing the impact of labeling on product liability litigation. Jessica will focus on analyzing the FDA's Draft Guidance on labeling biosimilar products as well as the best practices to market biosimilars to doctors and patients while protecting against liability.

Location

InterContinental New York Times Square
300 W. 44th St., New York, NY 10036

Event Registration

Services and Industries

Agenda

Monday, June 12, 2017 at 7:30 a.m. – Tuesday, June 13, 2017 at 5:00 p.m.

The Faegre Baker Daniels website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Baker Daniels' cookies information for more details.